Redo-Transcatheter Aortic Valve Replacement Procedural Optimization and Patient Selection: From Bench to Clinical...

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomedical Engineering

Background:

• Transcatheter aortic valve replacement (TAVR) guidelines now include younger patients, increasing the likelihood of future redo-TAVR procedures.
• Redo-TAVR is an emerging procedure with limited data, necessitating a thorough understanding of its safety and technical aspects.

Purpose of the Study:

• To review current data on the safety and feasibility of redo-TAVR.
• To highlight the importance of pre-procedural planning and transcatheter heart valve (THV) selection for successful redo-TAVR.
• To emphasize critical procedural elements for optimizing outcomes in redo-TAVR.

Main Methods:

• Analysis of current clinical registry data on redo-TAVR safety and outcomes.
• Review of bench studies focusing on optimal valve configurations, patient anatomy, and THV properties.
• Synthesis of technical considerations for procedural success in redo-TAVR.

Main Results:

• Registry data indicate excellent safety profiles for redo-TAVR, with low 30-day and 1-year mortality rates.
• Understanding valve configurations, patient anatomy, and THV characteristics is essential for patient selection and procedural success.
• The choice of the initial THV significantly impacts the feasibility of subsequent redo-TAVR.

Conclusions:

• Redo-TAVR is a safe and feasible procedure with favorable short-term outcomes.
• Lifetime management for TAVR patients must consider the initial valve choice to ensure future redo-TAVR success.
• Optimizing valve sizing, commissural alignment, and implant depth are critical for hemodynamic performance, valve longevity, and coronary access.